It may be because due to genotype differences, patients with HbH-CS disease are more anaemic, and ineffective hematopoiesis and iron overload are more serious, resulting in compensatory METTL16 and SLC5A3 decline reducing excessive iron entry into cells and reducing the increase of ROS caused by iron overload. The gene discussed is HBA2; the disease is glycogen storage disease VI.